At the time of writing, Xenon Pharmaceuticals Inc [XENE] stock is trading at $40.38, up 2.57%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XENE shares have gain 3.72% over the last week, with a monthly amount glided 0.10%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Xenon Pharmaceuticals Inc [NASDAQ: XENE] stock has seen the most recent analyst activity on October 01, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $53. Previously, Citigroup started tracking the stock with Buy rating on January 04, 2024, and set its price target to $62. On December 08, 2023, Robert W. Baird initiated with a Outperform rating and assigned a price target of $63 on the stock. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $58 as its price target on April 25, 2023. Goldman started tracking with a Buy rating for this stock on December 14, 2022, and assigned it a price target of $60. In a note dated December 12, 2022, Cowen initiated an Outperform rating.
For the past year, the stock price of Xenon Pharmaceuticals Inc fluctuated between $27.99 and $50.99. Currently, Wall Street analysts expect the stock to reach $51.75 within the next 12 months. Xenon Pharmaceuticals Inc [NASDAQ: XENE] shares were valued at $40.38 at the most recent close of the market. An investor can expect a potential return of 28.16% based on the average XENE price forecast.
Analyzing the XENE fundamentals
Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at -44.15%, Pretax Profit Margin comes in at -37.05%, and Net Profit Margin reading is -37.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -0.24 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 39.46 points at the first support level, and at 38.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.16, and for the 2nd resistance point, it is at 41.94.
Ratios To Look Out For
It is important to note that Xenon Pharmaceuticals Inc [NASDAQ:XENE] has a current ratio of 23.27. As well, the Quick Ratio is 23.27, while the Cash Ratio is 4.37.
Transactions by insiders
Recent insider trading involved GAROFALO ELIZABETH A., Director, that happened on Mar 08 ’24 when 2092.0 shares were sold. EVP, Strategy & Innovation, ROBIN SHERRINGTON completed a deal on Mar 07 ’24 to sell 7137.0 shares. Meanwhile, Director GANNON STEVEN sold 13000.0 shares on Mar 07 ’24.
